News
Our latest news
Revolutionizing Blood Sampling: Capitainer’s qDBS Technology in the SelectScience Spotlight
News | juni 2023
Capitainer’s self-sampling platform allows people to collect blood samples from their fingertips, anytime and anywhere, and […]
Application note from Waters on immunosuppressive drug analysis using Capitainer®B
News | maj 2023
In a new application note Waters describes a clinical research method using liquid-liquid extraction from Capitainer®B remot […]
Meet Capitainer at ASMS in Houston
Events | maj 2023
Visit us at booth # 123, at ASMS, the American Society for Mass Spectrometry Conference in Houston, USA, June 4-8th, 2023. C […]
Capitainer secures 5.7 MUSD to advance self-sampling technology and accelerate growth
Press release | maj 2023
Stockholm, 11 May 2023: Swedish medtech company Capitainer has raised just over 5.7 million USD to expand and commercialise […]
Capitainer recruits Sales & Distribution Manager to accelerate commercialisation of its self-sampling technology
Stockholm, May 08, 2023: Medical technology company Capitainer continues to focus on increased sales of its self-sampl […]
Capitainer launches fully automated sample handler
Press release | april 2023
Stockholm, April 04, 2023: Medical technology company Capitainer announces today the launch of a fully automated sample hand […]
Improved 17-OHP analysis with Capitainer®
News | februari 2023
The qDBS technology of Capitainer® was recently shown to significantly improve monitoring for PKU positive patients in the s […]
Capitainer is partner in the European Project SusFE (Innovative Processes & Methodologies for Next Generation Sustainable Functional Electronic Components and Systems)
Capitainer is proud to be one of nine partners in the European Project SusFE, funded by the European Commission’s Hori […]
Capitainer announces collaboration with AstraZeneca
Press release | januari 2023
Stockholm, January 30, 2023: The Swedish medtech company Capitainer AB today announces a research collaboration with AstraZe […]
